Cargando…

Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada

Aims. To assess trends in the incidence of pediatric diarrhea-associated hemolytic uremic syndrome (D(+) HUS) and document long-term renal sequelae. Methods. We conducted a retrospective cohort study of children with D(+) HUS admitted to a tertiary care pediatric hospital in Montreal, Canada, from 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Robitaille, Pierre, Clermont, Marie-José, Mérouani, Aïcha, Phan, Véronique, Lapeyraque, Anne-Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820622/
https://www.ncbi.nlm.nih.gov/pubmed/24278685
http://dx.doi.org/10.6064/2012/341860
_version_ 1782290171313520640
author Robitaille, Pierre
Clermont, Marie-José
Mérouani, Aïcha
Phan, Véronique
Lapeyraque, Anne-Laure
author_facet Robitaille, Pierre
Clermont, Marie-José
Mérouani, Aïcha
Phan, Véronique
Lapeyraque, Anne-Laure
author_sort Robitaille, Pierre
collection PubMed
description Aims. To assess trends in the incidence of pediatric diarrhea-associated hemolytic uremic syndrome (D(+) HUS) and document long-term renal sequelae. Methods. We conducted a retrospective cohort study of children with D(+) HUS admitted to a tertiary care pediatric hospital in Montreal, Canada, from 1976 to 2010. In 2010, we recontacted patients admitted before 2000. Results. Of 337 cases, median age at presentation was 3.01 years (range 0.4–14). Yearly incidence peaked in 1988 and 1994-95, returning to near-1977 levels since 2003. Twelve patients (3.6%) died and 19 (5.6%) experienced long-term renal failure. Almost half (47%) The patients required dialysis. Need for dialysis was the best predictor of renal sequelae, accounting for 100% of severe complications. Of children followed ≥1 year (n = 199, mean follow-up 8.20 ± 6.78 years), 19 had severe and 18 mild-to-moderate kidney injury, a total sequelae rate, of 18.6%. Ten years or more after-HUS (n = 85, mean follow-up 15.4 ± 5.32 years), 8 (9.4%) patients demonstrated serious complications and 22 (25.9%) mild-to-moderate, including 14 (16%) microalbuminuria: total sequelae, 35.3%. Conclusions. Patients with D(+) HUS should be monitored at least 5 years, including microalbuminuria testing, especially if dialysis was required. The cause of the declining incidence of D(+)HUS is elusive. However, conceivably, improved public health education may have played an important role in the prevention of food-borne disease.
format Online
Article
Text
id pubmed-3820622
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-38206222013-11-25 Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada Robitaille, Pierre Clermont, Marie-José Mérouani, Aïcha Phan, Véronique Lapeyraque, Anne-Laure Scientifica (Cairo) Clinical Study Aims. To assess trends in the incidence of pediatric diarrhea-associated hemolytic uremic syndrome (D(+) HUS) and document long-term renal sequelae. Methods. We conducted a retrospective cohort study of children with D(+) HUS admitted to a tertiary care pediatric hospital in Montreal, Canada, from 1976 to 2010. In 2010, we recontacted patients admitted before 2000. Results. Of 337 cases, median age at presentation was 3.01 years (range 0.4–14). Yearly incidence peaked in 1988 and 1994-95, returning to near-1977 levels since 2003. Twelve patients (3.6%) died and 19 (5.6%) experienced long-term renal failure. Almost half (47%) The patients required dialysis. Need for dialysis was the best predictor of renal sequelae, accounting for 100% of severe complications. Of children followed ≥1 year (n = 199, mean follow-up 8.20 ± 6.78 years), 19 had severe and 18 mild-to-moderate kidney injury, a total sequelae rate, of 18.6%. Ten years or more after-HUS (n = 85, mean follow-up 15.4 ± 5.32 years), 8 (9.4%) patients demonstrated serious complications and 22 (25.9%) mild-to-moderate, including 14 (16%) microalbuminuria: total sequelae, 35.3%. Conclusions. Patients with D(+) HUS should be monitored at least 5 years, including microalbuminuria testing, especially if dialysis was required. The cause of the declining incidence of D(+)HUS is elusive. However, conceivably, improved public health education may have played an important role in the prevention of food-borne disease. Hindawi Publishing Corporation 2012 2012-12-31 /pmc/articles/PMC3820622/ /pubmed/24278685 http://dx.doi.org/10.6064/2012/341860 Text en Copyright © 2012 Pierre Robitaille et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Robitaille, Pierre
Clermont, Marie-José
Mérouani, Aïcha
Phan, Véronique
Lapeyraque, Anne-Laure
Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada
title Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada
title_full Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada
title_fullStr Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada
title_full_unstemmed Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada
title_short Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada
title_sort hemolytic uremic syndrome: late renal injury and changing incidence—a single centre experience in canada
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820622/
https://www.ncbi.nlm.nih.gov/pubmed/24278685
http://dx.doi.org/10.6064/2012/341860
work_keys_str_mv AT robitaillepierre hemolyticuremicsyndromelaterenalinjuryandchangingincidenceasinglecentreexperienceincanada
AT clermontmariejose hemolyticuremicsyndromelaterenalinjuryandchangingincidenceasinglecentreexperienceincanada
AT merouaniaicha hemolyticuremicsyndromelaterenalinjuryandchangingincidenceasinglecentreexperienceincanada
AT phanveronique hemolyticuremicsyndromelaterenalinjuryandchangingincidenceasinglecentreexperienceincanada
AT lapeyraqueannelaure hemolyticuremicsyndromelaterenalinjuryandchangingincidenceasinglecentreexperienceincanada